This section contains information intended for healthcare professionals. Please certify that you are a healthcare professional.

Please indicate your country of residence:

What language is your preference?

Our mission

Our mission is to provide powerful tools that translate what is happening in a patients’ body into a readable and interpretable language.

We call it our new language of life. 

The “language of life” makes it easier to understand, diagnose and treat chronic and metabolic diseases produced by the modern way of life. Cancer, obesity, aging and depression share a common biology: they are metabolic and inflammatory. Those pathological imbalances lead to protein modification which require special separation techniques to give us a better understanding. Capillary Electrophoresis (CE) is the most accurate and efficient method of separation to unlock these complex conditions.

Sebia is a global specialized In Vitro Diagnostic player providing equipment and reagents for the screening and monitoring of various diseases, primarily in the areas of Oncology (Multiple Myeloma), Diabetes, Hemoglobinopathy, Autoimmune & Infectious diseases and other rare pathologies.

Headquartered in the South of Paris (Lisses, France), We set high standards in making continuous advances in CE technology, scientific excellence and manufacturing capabilities, providing Sebia the possibility to pursue diagnostic solutions with an exciting pipeline of new tests and automated equipment.

Our key figures

+1 200
employees worldwide
+120
countries covered
22
affiliates and representative offices
+20 000
installed instruments worldwide

Our history

1967
Guy Barouh establishes Sebia
1986
Launch of the HYDRAGEL range of products
1986
Germany office opens
1994
Introduction of the First HYDRASYS system
1996
Benelux office opens
1997
USA office opens
1998
Italy office opens
2001
Sebia introduces Capillary Electrophoresis (CE) technology
2001
Spain office opens
2004
Opening of the Lisses Headquarters in France
2005
First CAPILLARYS 2 system sold
2006
UK office opens
2007
Introduction of CE test for Hb
2007
China and Brazil offices opening
2011
Introduction of a CE test for HbA1c
2015
First CAPILLARYS 3 TERA system sold
2016
Acquisition of Interlab
2017
Introduction of the CAPILLARYS 3 TERA MC system
2017
Jean-Marc CHERMETTE is named CEO
2018
Switzerland office opens
2019
Extended CAPILLARYS 3 Family of Instruments (OCTA & TLA System)
2019
Portugal, India and UAE offices opening
2020
Canada office opens
2021
Singapore and Japan offices opening
2021
Acquisition of Orgentec
2022
South Korea, Czech Republic & Slovakia and Hungary offices opening
2022
Acquisition of Zeus Scientific
2023
Sweden & Romania offices opening

Learn more

R&D

Our R&D teams have 50 years of unique experience, perspective and knowledge; its this extensive understanding of Electrophoresis which allows us to read the new language of life.

Learn more

Join us

Within the Sebia Group everything is possible. If you want to live a great professional adventure, Join us!

Learn more

A worldwide presence

Over the years, Sebia has continuously strengthened its international footprint to better serve its customers.

Learn more

Employee testimonials

See all employee testimonials

Catherine HERNANDEZ – Chemistry Production Manager

Employee testimonial
May. 04, 2021

Find out what the role of a Chemistry Production Manager is.

Georges NOUADJE – R&D Manager

Employee testimonial
May. 04, 2021

Find out what the role of a R&D Manager is.

Nieves SANZ – Knowledge Center Advisor

Employee testimonial
May. 04, 2021

Find out what the role of a Knowledge Center Advisor is.